Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Arrhythmias and natriuretic polypeptides]

Minoru Horie1

  • 1Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Sciences.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 28, 2004
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ventricular conduction is a marker for arrhythmic risk in SCN5A-E1784K overlap sodium channel disease.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Differential responses of J waves to heart rate changes in idiopathic ventricular fibrillation and the general population in Japan.

Heart rhythm·2026
Same author

A Genome-Wide Association Study Reveals <i>Desmoglein-2</i> Predominance in Japanese Arrhythmogenic Cardiomyopathy.

Journal of arrhythmia·2026
Same author

Phenotypic Severity of <i>SCN5A</i>-Related Bradycardia Is Independent of Dominant-Negative and Coupled Gating Effects.

Circulation. Arrhythmia and electrophysiology·2026
Same author

Long-term follow-up of patients with catecholaminergic polymorphic ventricular tachycardia related to a novel <i>CALM2</i> variant.

Journal of cardiology cases·2026
Same author

Catecholaminergic polymorphic ventricular tachycardia mediated by ryanodine receptor 2: a validated risk stratification.

European heart journal·2025